Correlative Study on Incidence and Risk Factors of Glaucoma-related Adverse Event at Various Durations After Congenital Cataract Surgery
NCT ID: NCT04521907
Last Updated: 2020-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
177 participants
OBSERVATIONAL
2011-05-01
2020-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glaucoma After Congenital Cataract Surgery
NCT04342052
Glaucoma After Congenital And Infantile Cataract Surgery
NCT04131114
Glaucoma Following Pediatric Cataract Surgery
NCT05451745
Evaluation of Primary Congenital Glaucoma at Asyut University Hospital
NCT05205122
Study on Intraocular Structural Parameters and Surgical Effect Before and After the Onset of Malignant Glaucoma
NCT04220879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1 includes patients who underwent cataract surgery with primary IOL implantation
No interventions assigned to this group
Group 2
Group 2 includes patients who underwent cataract surgery with secondly IOL implantation
No interventions assigned to this group
Group 3
Group 3 includes patients who underwent cataract surgery without IOL implantation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yune Zhao
Vice president of Eye Hospital of Wenzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ophthalmology and Optometry Hospital
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
zhao yun-e
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRAE2 -zzh
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.